Evidence map›Paper›PMID 42118793›Full record

ArticlePloS one2026

Continuous high-fat high-sugar diet overrides the therapeutic potential of fecal microbiota transplantation from exercised and/or inulin-conditioned donors in obese mice.

Masato Kawashima, Takafumi Aoki, Hiroki Hamada, Chihiro Watanabe, Eri Oyanagi, Takumi Kono, Takashi Yamagata, Nicholas P West, Hiromi Yano

Abstract read
In one paragraph

Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Masato KawashimaDepartment of Humanities and Social Sciences, Institute of Liberal Arts, Kyushu Institute of Technology, Kitakyushu, Japan.ORCID https://orcid.org/0009-0003-1267-0263
Takafumi AokiDepartment of Clinical Nutrition, Kawasaki University of Medical Welfare, Kurashiki, Japan.
Hiroki HamadaDepartment of Health and Sports Science, Kawasaki University of Medical Welfare, Kurashiki, Japan.
Chihiro WatanabeDepartment of Health and Sports Science, Kawasaki University of Medical Welfare, Kurashiki, Japan.
Eri OyanagiDepartment of Health and Sports Science, Kawasaki University of Medical Welfare, Kurashiki, Japan.
Takumi KonoGraduate School of Health Science and Technology, Kawasaki University of Medical Welfare, Kurashiki, Japan.
Takashi YamagataDepartment of Health and Sports Science, Kawasaki University of Medical Welfare, Kurashiki, Japan.
Nicholas P WestSchool of Pharmacy and Medical Science and Central Facility for Genomics, Griffith University, Parklands Drive, QLD, Australia.
Hiromi YanoDepartment of Health and Sports Science, Kawasaki University of Medical Welfare, Kurashiki, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fecal microbiota transplantation (FMT) is a promising therapeutic strategy for obesity and related metabolic disorders. Exercise and dietary fiber intake, such as inulin supplementation, have been shown to differentially modulate the gut microbiota and synergistically improve metabolic health. The present study aimed to investigate whether FMT from lean donor mice subjected to voluntary exercise and/or inulin supplementation could ameliorate metabolic dysfunction in high-fat high-sugar diet (HFHSD)-induced obese mice. Four-week-old male C57BL/6J mice were fed HFHSD throughout the experimental period and assigned to one of five groups: sham FMT, FMT from sedentary donors, from exercised donors, from inulin-supplemented donors, or from donors receiving both interventions. Following 12 weeks of obesity induction, mice were treated with antibiotics and then underwent a 4-week FMT protocol. Physical and metabolic parameters, gut microbial composition, and cecal short-chain fatty acid (SCFA) levels were examined in both donors and recipients. The results demonstrated that FMT from exercised and/or inulin-supplemented donors failed to improve obesity-related phenotypes or glucose intolerance in recipients. These outcomes were accompanied by only partial alterations in gut microbiota and SCFA profiles. Collectively, our findings suggest that persistent HFHSD exposure compromises the colonization and function of beneficial microbes, limiting the metabolic benefits of FMT. Successful application of FMT in severe obesity may require prior optimization of the host intestinal environment through dietary interventions or microbiome-targeted strategies.

Indexed as

Diet, High-FatFecal Microbiota TransplantationInulinObesityPhysical Conditioning, AnimalAnimalsFatty Acids, VolatileGastrointestinal MicrobiomeMaleMiceMice, Inbred C57BLMice, ObeseFatty Acids, VolatileInulin

Identifiers

PMID42118793
PMCPMC13166953

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.